Abstract
The pharmaceutical market of Ukraine has undergone significant changes and challenges due to the ongoing war and associated economic difficulties. Military actions have resulted in substantial damage and destruction of production and logistics facilities, disruptions in the supply of medicines, reduced availability of pharmaceuticals for the population, and challenges in importing raw materials and finished drugs. On the other hand, this crisis situation has revealed new opportunities for the development of domestic production and localization of pharmaceutical products. This could strengthen the pharmaceutical sector, reduce dependence on imported drugs, and ensure long-term resilience of the industry during the reconstruction period. The aim of this study is to assess the current state of the pharmaceutical market in Ukraine, analyze the impact of the war on key aspects of the industry—production, logistics, import, and export of products—and explore opportunities for the sector’s adaptation and development in the post-war economy. Particular attention is paid to analyzing consumer demand, the availability of medicines, as well as the prospects for production localization, the development of generic drugs, strengthening national infrastructure, and improving the competitiveness of domestic products. The review indicates the necessity of strategic state support to create favorable conditions for the development of the pharmaceutical sector. This includes tax incentives for companies specializing in drug production, investment subsidies for the modernization and construction of new pharmaceutical plants, promotion of pharmaceutical clusters, and stimulation of scientific research and development. Key measures also involve supporting small and medium-sized pharmaceutical enterprises through financial and educational programs, creating microfinance opportunities for new manufacturing ventures, and developing training and certification programs to enhance the professional level of industry workers.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have